Evotec (OTCMKTS:EVTCY) Reaches New 52-Week Low at $10.39
hands. The company's stock price has been on a steady decline since early 2018.
( shares reached a new low for the 52-week period during Monday's trading. The stock traded as low at $10.39, and as recently as $10.54. A total of 5680 shares were traded. Stock had closed previously at $10.53.
Evotec Stock Performance
The company has a $3.48 billion market cap, a 25.68 price-to earnings ratio and a beta value of 0.98. The stock's 200-day moving average is $8.24 and its 50-day moving average $9.84. The company's current ratio is 2.57, its quick ratio is 2.50, and it has a debt to equity ratio of 0.53
Evotec Company profile
Get Rating
)
Evotec SE is engaged in the development and discovery of new drugs by pharmaceutical and biotechnology firms. It is divided into two segments: EVT Innovate and EVT Execute. The EVT Execute Segment provides integrated or stand-alone drug discovery solutions to collaborators, targets, and programmers. These are provided on a fee-for service basis, or via a variety commercial structures that may include performance-based elements, such as milestones, and royalties.
MarketBeat.com offers a FREE daily email newsletter
.